Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Bitto

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Geroscience|April 13, 2022
Age-related disruption of the proteome and acetylome in mouse hearts is associated with loss of function and attenuated by elamipretide (SS-31) and nicotinamide mononucleotide (NMN) treatmentJeremy A Whitson, Richard Johnson, Lu Wang, et al.
Chemmedchem|February 20, 2009
Design, synthesis, and biological evaluation of levoglucosenone-derived ras activation inhibitorsChristian Müller, Maria Antonia Gomez-Zurita Frau, Dario Ballinari, et al.
Carcinogenesis|February 25, 2009
Proepithelin is an autocrine growth factor for bladder cancerFrancesca Lovat, Alessandro Bitto, Shi-Qiong Xu, et al.
Molecular Genetics and Metabolism|April 26, 2020
Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial diseaseSimon C Johnson, Ernst-Bernhard Kayser, Rebecca Bornstein, et al.
Geroscience|July 7, 2021
University of Washington Nathan Shock Center: innovation to advance aging researchMatt Kaeberlein, Alessandro Bitto, Maitreya J Dunham, et al.
Aging Cell|August 12, 2020
SS-31 and NMN: Two paths to improve metabolism and function in aged heartsJeremy A Whitson, Alessandro Bitto, Huiliang Zhang, et al.
Kidney International|November 26, 2018
mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseasesSimon C Johnson, Frank Martinez, Alessandro Bitto, et al.
Frontiers in Genetics|August 11, 2015
Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in miceSimon C Johnson, Melana E Yanos, Alessandro Bitto, et al.
Elife|August 24, 2016
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged miceAlessandro Bitto, Takashi K Ito, Victor V Pineda, et al.
Frontiers in Genetics|December 30, 2017
Corrigendum: Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I DeficiencyTakashi K Ito, Chenhao Lu, Jacob Khan, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Geroscience|April 13, 2022
Age-related disruption of the proteome and acetylome in mouse hearts is associated with loss of function and attenuated by elamipretide (SS-31) and nicotinamide mononucleotide (NMN) treatmentJeremy A Whitson, Richard Johnson, Lu Wang, et al.
Chemmedchem|February 20, 2009
Design, synthesis, and biological evaluation of levoglucosenone-derived ras activation inhibitorsChristian Müller, Maria Antonia Gomez-Zurita Frau, Dario Ballinari, et al.
Carcinogenesis|February 25, 2009
Proepithelin is an autocrine growth factor for bladder cancerFrancesca Lovat, Alessandro Bitto, Shi-Qiong Xu, et al.
Molecular Genetics and Metabolism|April 26, 2020
Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial diseaseSimon C Johnson, Ernst-Bernhard Kayser, Rebecca Bornstein, et al.
Geroscience|July 7, 2021
University of Washington Nathan Shock Center: innovation to advance aging researchMatt Kaeberlein, Alessandro Bitto, Maitreya J Dunham, et al.
Aging Cell|August 12, 2020
SS-31 and NMN: Two paths to improve metabolism and function in aged heartsJeremy A Whitson, Alessandro Bitto, Huiliang Zhang, et al.
Kidney International|November 26, 2018
mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseasesSimon C Johnson, Frank Martinez, Alessandro Bitto, et al.
Frontiers in Genetics|August 11, 2015
Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in miceSimon C Johnson, Melana E Yanos, Alessandro Bitto, et al.
Elife|August 24, 2016
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged miceAlessandro Bitto, Takashi K Ito, Victor V Pineda, et al.
Frontiers in Genetics|December 30, 2017
Corrigendum: Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I DeficiencyTakashi K Ito, Chenhao Lu, Jacob Khan, et al.
Pageof 4